title: Labeling of the nicotinic acetylcholine receptor by a photoactivatable steroid probe: effects of cholesterol and cholinergic ligands.
abstract: A photoactivatable steroid, p-azidophenacyl 3 alpha-hydroxy-5 beta-cholan-24- ate (APL), has been synthesized and used instead of cholesterol to functionally reconstitute purified acetylcholine receptor (AcChR) into vesicles made of asolectin phospholipids. Upon irradiation, the extent of AcChR photolabeling by APL is directly proportional to the amount of APL incorporated into the reconstituted vesicles and the maximum stoichiometry observed corresponds to approx. 50 mol of APL bound per mol of AcChR. Furthermore, all four subunits of the AcChR become labeled by APL and the observed labeling pattern resembles the 2:1:1:1 stoichiometry characteristic of these subunits within the AcChR complex. The presence of either cholesterol or neutral lipids from asolectin in the reconstituted bilayer decreases both, the incorporation of APl into the vesicles and the covalent labeling of the AcChR upon irradiation, without altering the stoichiometry of labeling in AcChR subunits stated above. This suggests that the potential interaction sites for the photoactivatable probe in the reconstituted AcChR are mostly those normally occupied by the natural neutral lipids. Carbamylcholine, a cholinergic agonist, also reduces the extent of APL photolabeling of the AcChR in a dose-dependent manner but, in contrast to the effects of cholesterol, the presence of carbamylcholine alters the stoichiometry of labeling in the AcChR subunits. This, along with the observation that such a decrease in the extent of APL photolabeling caused by carbamylcholine can be blocked by preincubation with alpha-bungarotoxin, suggest that AcChR desensitization induced by prolonged exposure to cholinergic agonists encompasses a rearrangement of transmembrane portions of the AcChR protein, which can be sensed by the photoactivatable probe. Conversely, presence of (+)-tubocurarine, a competitive cholinergic antagonist, has no effects on altering either the extent of APL photolabeling of the AcChR or the distribution of the labeling among AcChR subunits.
authors.affiliation: Department of Neurochemistry, University of Alicante, Spain.
authors.forename: A M
authors.initials: AM
authors.lastname: Fernandez
authors.forename: G
authors.initials: G
authors.lastname: Fernandez-Ballester
authors.forename: J A
authors.initials: JA
authors.lastname: Ferragut
authors.forename: J M
authors.initials: JM
authors.lastname: Gonzalez-Ros
mesh_terms: D000345:Affinity Labels; D000818:Animals; D001386:Azides / Q000138:chemical synthesis; D001665:Binding Sites; D002152:Calorimetry, Differential Scanning; D002784:Cholesterol / Q000031:analogs & derivatives* / Q000737:chemistry / Q000494:pharmacology; D008095:Lithocholic Acid / Q000031:analogs & derivatives / Q000138:chemical synthesis; D008562:Membrane Glycoproteins / Q000737:chemistry / Q000187:drug effects*; D010777:Photochemistry; D011978:Receptors, Nicotinic / Q000737:chemistry / Q000187:drug effects*; D014101:Torpedo
chemical_list: D000345:Affinity Labels; D001386:Azides; D008562:Membrane Glycoproteins; D011978:Receptors, Nicotinic; C081891:4-azidophenacyl lithocholate; D008095:Lithocholic Acid; D002784:Cholesterol